BayHelix names Goodwin’s Pan chair, gives BioCentury’s Flores achievement award

BayHelix announced Goodwin’s Wendy Pan as its new chair and gave BioCentury President and CEO David Flores a lifetime achievement award. Pan will succeed Guo-Liang Yu, chairman and CEO of Apollomics Inc. (NASDAQ:APLM), and will lead a board that includes returning member Jian Shao and new members Mark Tang, Angela Wang and Ying Yang.

Flores, who co-founded BioCentury with Chairman Karen Bernstein in 1993, has championed cross-border collaboration and global drug development for more than three decades, including at such BioCentury and BayHelix conferences as the China Healthcare Summit and the East-West Biopharma Summit...